Transcriptome studies reveal many noncoding transcripts overlapping 3′ gene termini. The function of these transcripts is unknown. Here we have characterized transcription at the progesterone receptor (PR) locus and identified noncoding transcripts that overlap the 3′ end of the gene. Small RNAs complementary to sequences beyond the 3′ terminus of PR mRNA modulated expression of PR, recruited argonaute 2 to a 3′ noncoding transcript, altered occupancy of RNA polymerase II, induced chromatin changes at the PR promoter and affected responses to physiological stimuli. We found that the promoter and 3′ terminal regions of the PR locus are in close proximity, providing a potential mechanism for RNA-mediated control of transcription over long genomic distances. These results extend the potential for small RNAs to regulate transcription to target sequences beyond the 3′ termini of mRNA.
M odulation of gene expression in mammalian cells by small duplex RNAs is typically associated with recognition of mRNA 1 . Reports suggest that duplex RNAs complementary to gene promoters can silence or activate gene expression in mammalian cells [2] [3] [4] [5] [6] . Argonaute 2 (AGO2), a key protein involved in RNA interference (RNAi) 7 , is required for the action of promotertargeted RNAs 5, 8 , and a related protein, AGO1, has also been implicated in the mechanism 9 . The mechanism of promoter-targeted RNAs may involve recognition of noncoding transcripts that overlap gene promoters 10, 11 . Over 70% of all genes have noncoding transcripts that overlap their promoters, and these transcripts provide potential target sites for small RNA duplexes [12] [13] [14] [15] [16] [17] .
Promoter-targeted RNAs are robust modulators of progesterone receptor (PR) transcription in T47D and MCF7 breast cancer cells 4, 6, 8, 11 . We term these small RNAs antigene RNAs (agRNAs) to distinguish them from duplex RNAs that target mRNA. The main difference between activation or inhibition of gene expression by closely related agRNAs is the basal expression of PR. Gene silencing is observed in T47D cells that constitutively express PR at high basal levels, whereas activation of PR expression is observed in MCF7 cells that express PR at low levels 6 .
Both activating and inhibitory agRNAs modulate PR expression through binding to complementary target sequences within an antisense transcript that originates from inside the PR gene and is transcribed through the promoter region. agRNAs recruit AGO protein to the antisense transcript, affect levels of RNA polymerase II (RNAP2) at the promoter and alter the mix of regulatory proteins that bind the antisense transcript and the PR promoter 11 .
Noncoding RNAs also overlap the 3′ untranslated region (3′ UTR) of many genes [15] [16] [17] . The 3′ UTR plays a major role in cellular regulation and disease pathology 18 and is involved in a variety of posttranscriptional processes, including mRNA transport, localization and stability. The function of 3′ noncoding transcripts is unclear, but their proximity to the 3′ UTR suggests that they may affect gene regulation.
There has been little investigation into the potential function of overlapping noncoding transcripts at the 3′ region of genes, and no examination of whether these noncoding transcripts might be targets for modulating gene expression by duplex RNAs. The abundance of transcripts that overlap the 3′ UTR, coupled with the ability of agRNAs to modulate gene expression by targeting overlapping 5′ transcripts, suggested that small RNAs might also influence gene expression by recognizing sequences beyond the 3′ end of genes. Here we investigate the potential for small RNAs to recognize regions beyond the 3′ termini of mRNAs and regulate gene expression.
RESULTS

Characterization of the 3′ region of PR mRNA
Working with agRNAs requires accurate identification of mRNA termini. Initially, the PR GenBank sequence was inaccurately labeled, with the 5′ end extended too far upstream and the 3′ terminus prematurely truncated (Fig. 1a, top) . Northern analysis suggested lengths for PR mRNA variants 19 but lacked a precise length for the largest variant (estimated to be 11.4 kilobase pairs (kb)) ( Fig. 1a, middle) . A GenBank update based on a cluster of expressed sequence tags later extended the 3′ UTR downstream to +13,037 (Fig. 1a, bottom) .
We performed northern analysis (Supplementary Methods and Supplementary Results) with probes complementary to the protein-encoding region of PR mRNA (probe 1), the terminus of PR mRNA at +13,037 predicted by the recent GenBank update (probe 2) and a region immediately downstream from the predicted +13,037 terminus (probe 3) ( Supplementary Fig. 1a and Supplementary  Table 1 ). Probe 1 yielded major products at ~5.5 kb and >10 kb, similar to results observed previously 19 (Supplementary Fig. 1b ). Probe 2 (complementary to the region at the predicted PR terminus) yielded only the >10 kb band (Supplementary Fig. 1b,c) , consistent with the conclusion that the band is full-length PR mRNA. Probe 3 (complementary to the region immediately downstream of +13,037) did not detect transcript ( Supplementary Fig. 1c ). Quantitative PCR (qPCR) revealed that RNA levels were relatively constant before abruptly dropping after nucleotide +13,037 ( Supplementary  Fig. 1d,e and Supplementary Table 2 ). 5′ and 3′ rapid amplification of cDNA ends (RACE) detected polyadenylation sites near +13,037 ( Supplementary Fig. 2 and Supplementary Table 3 ). article NATURE CHEmICAL bIoLogy dOI: 10.1038/nCHeMBIO.400
Transcripts at the 3′ terminus of PR mRNA
We used 3′ and 5′ RACE to search for noncoding transcripts that overlap the 3′ terminus of PR and identified transcripts that are transcribed in the sense orientation (in other words, synthesized in the same direction) relative to PR mRNA ( Fig. 1b-d, Supplementary  Figs. 1 and 2) . These 3′ transcripts shared a transcription start site at +11,325 and multiple poly(A) sites 1,400-1,500 bases downstream from the +13,037 terminus of PR mRNA. We did not detect antisense transcripts in this region.
As the 3′ transcript was transcribed in the same direction as PR mRNA, we tested whether it was a long variant of PR mRNA. We performed RT-PCR using a forward primer (primer E) comple mentary to PR mRNA that was directly upstream of +11,325 (and therefore had no complementarity to the +11,325-to-+14,546 transcript) and a reverse primer (primer G) upstream of +14,546 ( Fig. 1c) . We did not detect amplified product ( Fig. 1e and Supplementary  Fig. 2c,d) . By contrast, RT-PCR using a forward primer (primer F) directly downstream of +11,325 and reverse primer directly upstream of +14,546 (primer G) detected the +11,325-to-+14,546 product ( Fig. 1e) . Sequencing confirmed the identity of the amplified primer F-primer G product as the +11,325-to-+14,546 transcript and revealed that the transcript was unspliced ( Supplementary  Fig. 2e ). Beyond the +14,546 terminus of the noncoding transcript, qPCR revealed that RNA levels drop abruptly in both T47D and MCF7 cells ( Fig. 1f,g and Supplementary Fig. 1d,e ). RT-PCR with one primer (primer F) complementary to a sequence shared by PR mRNA and the 3′ noncoding transcript and another primer (primer H) downstream from +14,546 detected no product, suggesting that the mRNA does not extend past +13,037 ( Fig. 1e) .
RNAP2 transcribes genes beyond their poly(A) sites with subsequent cleavage of the transcript to form the mature mRNA. Our PCR did not detect evidence for longer PR mRNA ( Fig. 1e) , but we cannot with certainty exclude its existence or its involvement in the mechanism of 3′ agRNAs. qPCR revealed that the 3′ noncoding transcript was almost entirely in the nuclear fraction of cell lysates whereas PR mRNA was mostly in the cytoplasm (Supplementary Fig. 3 ).
We verified our data using the branched DNA (bDNA) assay ( Supplementary Fig. 4 ). The bDNA assay directly detects RNA using strand-specific probes that allow discrimination of sense and antisense transcripts. A probe set complementary to the sense transcript beyond +13,037 detected RNA at ~4% relative to the level of PR mRNA in either T47D or MCF7 cells. Assays with a probe set designed to detect a possible antisense transcript downstream from +13,037 suggested that an antisense transcript either was not present or was present at levels too low to detect.
Target sequences for duplex RNAs
We chose target sequences within the +11,325/+14,546 region of the 3′ noncoding transcript but downstream from +13,037 terminus of PR mRNA ( Fig. 1b and Supplementary Table 4 ). We numbered duplex RNAs by the position of the most upstream base relative to the +1 transcription start site for PR mRNA. We also tested duplex RNAs that target the PR promoter or PR mRNA to allow comparisons with other modulatory RNAs. We previously characterized agRNAs that target the promoter region (5′ agRNAs) and modulate PR expression. PR-11 targets the region from −11 to +8 relative to the transcription start site and activates PR transcription in MCF7 and T47D cells 6 . PR-9 targets the region from −9 to +10 and is a robust transcriptional silencing agent in T47D cells 4 . PR3593 and PR2526 target PR mRNA. The nomenclature for mismatchcontaining RNAs is based on the parent fully complementary RNA. For example, PR13515_MM3 has three mismatched bases relative to parent RNA PR13515.
gene inhibition by targeting beyond the 3′ UTR
We tested several 3′ agRNAs complementary to sequences downstream from the +13,037 terminus of PR mRNA ( Fig. 1b and Supplementary  Table 4 ). agRNAs PR13485 and PR13580 inhibited PR protein expression in T47D cells ( Fig. 2a and Supplementary Fig. 5 ). PR has two major protein isoforms, PRB and PRA 19 , and both isoforms appear as distinct bands during western analysis. The half-maximal inhibitory concentration value (IC 50 ) for inhibition of PR13580 was 10.7 nM, similar to the value for inhibition by mRNA-targeting RNA PR2526, article NATURE CHEmICAL bIoLogy dOI: 10.1038/nCHeMBIO.400 11.5 nM ( Fig. 2b and Supplementary Fig. 6 ). Mismatch-containing duplex RNAs did not inhibit gene expression. Some of the control RNAs maintained the potential for seed sequence 20 recognition of the duplex (PR13485_MM3, PR13580_MM3), demonstrating that seed sequence comple mentarity is not sufficient to induce the observed silencing ( Fig. 2a) .
Small RNAs can induce off-target effects through induction of the interferon response 21 . Inhibitory 3′ agRNA PR13580 did not significantly enhance expression of interferon-responsive genes (Supplementary Fig. 7a ) and was chosen for detailed investigation. Addition of poly(I:C), a potent inducer of the interferon response, did not alter PR gene expression ( Supplementary Fig. 7b ).
We used qPCR to investigate how addition of inhibitory agRNA PR13580 affected RNA levels throughout the PR locus ( Fig. 2c and Supplementary Table 5 ). Our strategy was to use different primer sets, each designed to amplify a different RNA species including (i) the 5′ antisense transcript at the PR promoter previously implicated in agRNA-mediated control of transcription 11 , (ii) the protein encoding region for PR mRNA, (iii) intron 7 within PR pre-mRNA, an indicator of whether gene modulation occurs before or after splicing and (iv) the +11,325/+14,546 noncoding transcript overlapping the terminus of PR mRNA (Fig. 1b) .
Addition of agRNA PR13580 to T47D cells reduced levels of PR mRNA ( Fig. 2c) . We also observed reduced levels of PR pre-mRNA, suggesting that modulation of RNA occurs before splicing. qPCR revealed reduced levels of the noncoding transcript downstream from the terminus of the 3′ UTR and 5′ noncoding transcript overlapping the transcription start site of PR. Negative control duplex RNA PR13063 did not reduce levels of PR mRNA (Supplementary Fig. 8 ).
The bDNA assay yielded similar results ( Supplementary Fig. 9 ).
To test whether agRNAs targeted to sequences beyond the 3′ UTR altered gene transcription, we measured RNAP2 occupancy at the PR promoter ( Supplementary Table 6 ). Chromatin immunoprecipitation (ChIP) revealed that duplex agRNA PR13580 reduced occupancy of RNAP2 at the promoter (Fig. 2d) . We also measured levels of the histone modification H3K27me3 (trimethylation of histone H3 at position Lys27), which serves as a chromatin-level marker for gene silencing 22 . Addition of PR13580 to T47D cells led to a 27-fold increase in H3K27me3 levels within the PR gene, relative to cells treated with mismatched control duplex ( Fig. 2e) . Addition of promoter-targeted agRNA PR-9 also caused changes in RNAP2 occupancy and levels of H3K27me3. RNA PR3593, which targets PR mRNA, did not decrease RNAP2 occupancy ( Fig. 2d) , emphasizing a basic difference in mechanism between agRNAs (inhibition of transcription) and duplex RNAs that function through post transcriptional gene silencing (PTGS) (inhibition of translation).
gene activation by targeting beyond the 3′ UTR
We hypothesized that agRNAs complementary to sequences beyond the 3′ terminus of PR might also yield enhanced gene expression in MCF7 cells, a cell line in which PR expression is low and increased expression is easily detectable. agRNA PR13515 increased levels of PR protein and mRNA ( Fig. 3a-c) . Levels of PR pre-mRNA increased ( Fig. 3c) , consistent with the suggestion that RNA levels increase before splicing. For comparison, we also measured RNA levels after addition of agRNA PR-11 that was complementary to the transcript of the PR promoter and 5′ noncoding RNA 11 and observed similar effects with all primer sets (Fig. 3c) . The bDNA assay also revealed increased levels of PR mRNA and the 3′ noncoding transcript upon addition of PR13515 or PR-11 ( Supplementary Fig. 9c ).
Addition of either PR-11 or PR13515 enhanced RNAP2 recruitment at the PR transcription start site ( Fig. 3d ) and caused a decrease in the silencing marker H3K27me3 (Fig. 3e) . The similarity of gene activation between PR-11 and PR13515 reinforced the idea that modulation of gene transcription by agRNAs proceeds through similar mechanisms regardless of whether the target regions are located beyond the 5′ or 3′ boundaries of mRNA.
We tested whether increased stability of PR mRNA contributed to its increased cellular levels after treatment with PR13515. Actinomycin D, a small molecule that inhibits transcription 23 , was added to cells that had been treated previously with PR13515 or PR-11. The half-life of PR in MCF7 cells is 7-10 h 24 . In MCF7 cells treated with either PR13515 or PR-11, addition of actinomycin D reversed the agRNA-mediated increase in PR mRNA. PR mRNA levels decreased by 8-10-fold within 30 h. (Fig. 3f) . These data suggested that increased levels of PR mRNA were due to enhanced transcription.
We tested several control RNAs to evaluate specificity. Control RNA PR13515_MM4 contained mismatched bases substituted throughout the sequence of PR13515. Control RNAs PR13515_MM3 and PR13515_MM3B had mismatched bases clustered to preserve the potential for off-target effects that might arise from seed sequence complementarity 21 . These control RNAs did not enhance protein expression ( Fig. 3a) . PR13515 did not increase expression of interferon-responsive genes, and activation of the interferon response did not increase PR expression ( Supplementary  Fig. 7c,d) . Off-target effects are a concern whenever duplex RNAs are introduced into cells. Our 3′ and 5′ agRNAs have partial complementarity to other genes, but these matches do not suggest any source for off-target regulation of PR.
Combining physiological stimuli and agRNAs
17β-Estradiol is a potent and well-characterized activator of PR gene expression in breast cancer cells 24 . Conversely, expression of PR decreases in cells grown in medium containing charcoal-stripped serum and supplemented with either interleukin-1β (IL-1β) or epidermal growth factor (EGF) [25] [26] [27] . We investigated how these physiological stimuli would affect expression of the 3′ and 5′ noncoding transcripts (Fig. 4a,b and Supplementary Table 7 ). Growth of T47D or MCF7 cells in charcoal-stripped serum reduced PR mRNA levels. Addition of EGF or IL-1β further reduced levels of PR mRNA, whereas addition of 17β-estradiol increased PR mRNA expression. In all cases, levels of the 3′ noncoding transcript varied proportionally with PR mRNA (Fig. 4a,b) . By contrast, expression of the 5′ non coding transcript did not change significantly in T47D or MCF7 cells grown in charcoal-stripped serum or in medium supplemented with 17β-estradiol. Addition of EGF or IL-1β decreased expression of the 5′ transcript in MCF7 cells.
We then tested whether the addition of agRNAs would affect regulation of PR expression by physiologically relevant stimuli and, conversely, whether physiological stimuli could block the action of agRNAs (Fig. 4c,d and Supplementary Fig. 10 ). Addition of inhibitory 3′ agRNA PR13580 to T47D cells cultured in charcoalstripped serum supplemented with IL-1β or EGF led to a proportionate reduction in expression of PR mRNA and the 3′ noncoding transcript to levels lower than those achieved by the physiological treatments alone. Treating cells with 17β-estradiol increases PR mRNA expression ( Fig. 4a,c) . Inhibitory agRNA PR13580 reversed this effect, leading to low expression of PR ( Fig. 4c) and almostunchanged expression of the 5′ noncoding transcript regardless of physiological treatment.
In MCF7 cells, addition of activating agRNA PR13515 in combination with 17β-estradiol yielded enhanced activation of PR gene expression to levels substantially above those achieved by addition of 17β-estradiol or PR13515 alone (Fig. 4d) . PR13515 reversed the repressive effects of growth in charcoal-stripped serum, EGF addition and IL-1β addition on PR expression ( Fig. 4d) . These data suggested 
Recruitment of argonaute to noncoding RNAs
Duplex agRNAs PR-9 and PR-11 are complementary to sequences within the PR promoter and recruit AGO protein to a non coding transcript that overlaps the PR gene promoter 11 . The sense noncoding transcript overlapping the 3′ terminus of the PR gene (Fig. 1b) contains complementary target sites for inhibitory or activating agRNAs PR13580 and PR13515 and was a candidate for involvement in RNA-mediated gene modulation. We used RNA immunoprecipitation (RIP) 28 from isolated nuclei with an anti-AGO2 antibody ( Fig. 5, Supplementary Table 8 and Supplementary Fig. 11 ) to examine recruitment of AGO2 protein to the 3′ noncoding transcript during modulation of gene expression by agRNAs. When we added silencing agRNA PR13580 to T47D cells (Fig. 5a) or activating agRNA PR13515 to MCF7 cells (Fig. 5b) , we observed association between AGO2 and the 3′ noncoding transcript. 5′ agRNAs targeting a noncoding RNA at the PR promoter showed similar recruitment of AGO2 to the 5′ noncoding transcript (Fig. 5c,d) . Sequencing confirmed the identity of the RIP products ( Supplementary Fig. 11 ). RIP with an anti-AGO1 antibody did not detect association of AGO1 (Supplementary Fig. 12 ). Inhibition of AGO2 expression with an anti-AGO2 siRNA reversed gene silencing by PR13580. Inhibition of AGO1, AGO3 or AGO4 expression did not reverse gene silencing (Supplementary Fig. 13) . These data are consistent with a primary role for AGO2.
We observed the same results when using a well-characterized antibody that recognizes all four AGO proteins 29 (Supplementary  Fig. 14a-d) . Identical RIP results using two different anti-AGO antibodies support the specificity of AGO involvement in the mechanism of 3′ agRNAs. No product was observed in the absence of reverse transcriptase (Supplementary Fig. 15 ) or after transfection of cells with mismatch-containing duplex RNAs. Cytoplasmic proteins GAPDH and tubulin were not detected in the nuclei, indicating that we are not detecting interactions in the cytoplasm.
Cleavage of the 3′ noncoding transcript is not detected
Small RNAs that are complementary to mRNA can induce cleavage of their target transcripts 1 . An important question of mechanism is whether 3′ agRNAs act by promoting cleavage of the 3′ noncoding transcript. We readily detected cleavage of PR mRNA by PR2562, a duplex RNA that is complementary to the coding region of PR mRNA (Supplementary Fig. 16 ).
We did not detect cleavage of the 3′ noncoding RNA using silencing agRNA PR13580 in T47D cells or activating agRNA PR13515 in MCF7 cells (Supplementary Fig. 16) . The 3′ noncoding transcript was expressed at relatively low levels, and it is possible that cleavage might occur without being detectable by 5′ RACE. Failure to detect any cleavage, however, was consistent with our observation that addition of PR13515 enhances levels of the 3′ noncoding transcript (Fig. 3c) rather than reducing those levels as would be predicted if transcript cleavage were occurring. It was also consistent with previous results showing that 5′ agRNA PR-11 does not alter levels of the 5′ noncoding transcript and does not cause detectable cleavage of the transcript 6 and with RIP data showing association of AGO2, because the transcript must be intact if it is to be detected during RIP.
overexpression of 3′ RNA does not affect PR mRNA levels
It is possible that the 3′ noncoding transcript recruits AGO2 protein before its release from chromosomal DNA. Alternatively, the 3′ noncoding transcript might be released from the chromosome and subsequently return to act at the PR locus. This latter mechanism would be similar to the mechanisms of protein transcription factors that are synthesized in the cytoplasm and return to act on their target promoters in the nucleus.
To examine the effect of altered cellular levels of the 3′ noncoding transcript and PR mRNA, we cloned and overexpressed the 3′ noncoding transcript in three breast cancer cell lines with varying basal PR expression levels (T47D (high), MCF7 (low) and MDA-MB231 (undetectable)). Overexpression of the 3′ noncoding transcript by as much as 100-fold above endogenous levels did not yield a significant change in PR mRNA levels in any of these three cell lines (Supplementary Fig. 17) . These results suggest that the cellular concentration of 3′ noncoding RNA does not affect PR expression. must be exerted over a long distance because the genomic locations of the PR promoter and the agRNA target sites are ~100 kb apart. Previous reports suggest that gene promoters and termini can be held in close proximity to one another [30] [31] [32] . Such proximity might facilitate the modulation of gene expression between otherwise distant 3′ and 5′ regions. We investigated whether the promoter and terminal regions of PR might also be in proximity using chromosome conformation capture (3C) analysis 31, 32 , a technique that examines the proximity of sequences within chromosomal DNA. In this technique, chromosomal DNA is cross-linked, digested with restriction enzyme and treated with DNA ligase to join DNA ends that are in close proxi mity. After reversal of cross-links, the DNA is amplified and sequenced to evaluate the proximity of target regions. We examined amplification of 3C products using multiple primer sets that vary in distance from the 5′ promoter and 3′ terminal regions of PR ( Fig. 6a and  Supplementary Table 9 ). For example, amplification by primer T2 (complementary to a sequence beyond the PR 3′ UTR termini) and primer F2 (complementary to sequences within PR exon 1) would only be predicted to occur if the 5′ and 3′ ends of the PR locus are held in proximity by gene looping.
gene looping brings 5′ and 3′ sequences into proximity
We observed ligation of the 5′ promoter region of the PR gene to the 3′ terminal regions in T47D (Fig. 6b) and MCF7 (Fig. 6c) cells.
Even though expression of PR was much higher in T47D than MCF7 cells, we did not detect a difference in the relative amount of looping ( Supplementary Figs. 18 and 19) . Addition of inhibitory agRNAs PR13580 or PR-9 to T47D cells or activating agRNAs PR13515 or PR-11 to MCF7 cells did not affect the relative amount of looping at the PR locus (Fig. 6b,c, Supplementary Figs. 20 and 21) .
We also examined the effects of physiological stimuli on looping. We have previously described the effects on PR expression of adding estrogen, growing cells in serum-stripped medium, treating cells with epidermal growth factor (EGF) or adding IL-1β (Fig. 4) . These treatments did not change the relative amounts of gene looping (Supplementary Fig. 22) . Our data suggest that gene looping at the PR locus remains constant under a range of different cell types, environmental stimuli and agRNA treatments.
It is most likely that the looping is intrachromosomal between the termini of a single PR gene. We are unaware of evidence for interchromosomal contacts between different alleles of the same gene on different chromosomes, but we note that such contacts may be possible.
Proximity of 5′ and 3′ noncoding transcripts
We investigated the possibility that gene looping might allow the 5′ and 3′ noncoding transcripts to form long-distance associations. We used RIP with anti-AGO2 antibodies to examine the proximity of the noncoding transcript at the 3′ UTR to the noncoding transcript at the PR promoter. Addition of inhibitory 3′ agRNA PR13580 (Fig. 5e ) or activating 3′ agRNA PR13515 (Fig. 5f ) followed by RIP led to detection of the 5′ noncoding transcript. Similarly, addition of duplex agRNAs complementary to the PR promoter, inhibitory agRNA PR-9 ( Fig. 5g) and activating agRNA PR-11 ( Fig. 5h) led to recovery of the 3′ noncoding transcript.
RIP uses a chemical cross-linking step that allows detection of factors within a complex. Therefore, it is not necessary for association between the 3′ and the 5′ noncoding transcripts to be direct. A more likely explanation is that the association between these noncoding RNAs is indirect. There may be a ribonucleoprotein complex containing AGO and the 5′ noncoding and 3′ non coding transcripts. We observed the same results when using a second anti-AGO antibody 29 (Supplementary Fig. 14e-h) .
Inhibition of BRCA1 expression by 3′ agRNAs
To test whether gene modulation by 3′ agRNAs might apply to other genes, we targeted sequences beyond the 3′ UTR of the tumor suppressor breast cancer-associated gene 1 (BRCA1). We chose BRCA1 because its 3′ termini had been well characterized 33 , its expression is lowered in a significant percentage of human cancers 34 , it is expressed in T47D breast cancer cells and the chromosomal loci juxtapose its promoter and termination regions 31 . 3′ RACE and qPCR confirmed the previously reported 35 termination site for BRCA1 mRNA (Supplementary Fig. 23 and Supplementary  Tables 10-12 ). 3C analysis confirmed that the BRCA1 promoter and 3′ terminal regions are in proximity (Supplementary Fig. 24 ).
3′ agRNAs inhibited expression of BRCA1 protein, mRNA and pre-mRNA ( Supplementary Fig. 25 and Supplementary Table 4 ). BRCA7851 reduced levels of RNAP2 at the BRCA1 promoter. An siBRCA 35 complementary to BRCA1 mRNA did not decrease recruitment of RNAP2 to the BRCA1 promoter. The 3′ agRNAs did not activate interferon responsive genes (Supplementary Fig. 6e,f) . These data suggested that 3′ agRNAs can also regulate expression of BRCA1.
DISCUSSIoN
Our data show that duplex RNAs can modulate transcription by targeting sequences beyond the 3′ UTR. These results (i) expand the pool of RNA transcripts that can be targeted by small RNAs; (ii) suggest that interactions encoded beyond the 3′ UTR can be important; (iii) show that RNA-mediated recognition can control transcription over a 100,000 base distance; (iv) are consistent with gene looping as an explanation for the long-distance control of transcription by RNA; (v) demonstrate that agRNAs can counteract or supplement the effects of physiological stimuli; and (vi) uncover additional layers of regulation and gene structure at the PR locus. agRNAs that target the 5′ promoter region have similar effects on gene expression and involve the essential RNA-binding protein AGO, suggesting that the mechanisms of 3′ agRNAs and 5′ agRNAs are related.
Overexpression of the 3′ noncoding RNA did not affect expression of PR (Supplementary Fig. 17) , consistent with the suggestion that the 3′ noncoding RNA species becomes involved in the complex before dissociation from chromosomal DNA. Proximity of the newly synthesized RNA to the proteins controlling gene transcription would simplify the challenge of initiating gene-specific inhibition of transcription by increasing the effective concentration of the RNA relative to genomic DNA. Once noncoding RNA leaves the target chromosomal locus, it would face greater obstacles returning and forming sequence-selective interactions upon addition of complementary agRNA.
Our RNA immunoprecipitation data suggested that non coding RNAs are the direct molecular targets of agRNAs, rather than sequences within chromosomal DNA. AGO2 appeared to play a critical role in the mechanism by promoting binding of the agRNA to the noncoding transcript. After being recruited to the noncoding transcript, AGO2 may form interactions with other proteins or disrupt existing interactions. We have previously shown that agRNAs modulate recruitment or displacement of other proteins such as HP1γ and hnRNPk and also alter histone modifications 11 . A scheme showing a potential orientation of noncoding transcripts, PR genomic DNA, AGO2 and 3′ agRNA is presented in Figure 7 . Although AGO2 is the best candidate for involvement and we did not observe cleavage of the target transcript, additional experiments will be needed to fully investigate involvement of AGO1, AGO3 or AGO4, as well as whether or not the target transcript is cleaved.
How can transcription be affected by an RNA-mediated binding event across 100,000 bases ( Fig. 7a) ? Three lines of evidence support the conclusion that the PR gene 'loops' (juxtaposes its 3′ and 5′ termini) ( Fig. 7b) : (i) striking similarity in the properties of 3′ and 5′ agRNAs, (ii) 3C analysis demonstrating proximity of 5′ promoter and 3′ terminus regions and (iii) RNA immunoprecipitation showing association of the 3′ and 5′ noncoding transcripts. Gene looping has been observed at the X-inactivation center 36 . The X-inactivation center controls transcriptional inactivation of the X chromosome in females and is regulated by noncoding RNAs Xist, Tsix and Xite. 3C analysis indicates that the loci for these noncoding RNAs are positioned close enough for interactions during the inactivation process, and the molecular mechanism may be related to the mechanism of agRNA-mediated gene regulation that we observe.
Although the molecular basis for the action of nuclear hormone receptors and other protein regulators is still not completely understood after many years of study, insights into how proteins control transcription provide a framework for broadly understanding the mechanism of agRNAs. Like our agRNAs, nuclear hormone receptors recognize specific sequences. For nuclear hormone receptors, ligand binding controls recognition of a coactivator or corepressor protein, whereas agRNAs recruit AGO2. Endogenous RNA coactivators and transcriptional activators have already been identified [37] [38] [39] , and it is possible that agRNAs and the agRNA-AGO2 complex may make similar interactions at gene promoters. More generally, many transcription factors have domains that contain RNA-binding motifs 39, 40 . The HIV-1 Tat protein is an especially compelling example because it binds a viral transcript and interacts with other proteins to control transcription 41, 42 .
Both 3′ and 5′ agRNAs regulate the levels of PR transcripts. Why do we observe activation under some conditions and inhibition under others? Expression of PR is poised to respond to in vivo signals such as hormones, cytokines and growth factors 24, 25 . The primary difference between agRNA-mediated activation and repression is that activation is more easily observed in cells that express low basal levels of PR (cells poised to increase expression) whereas inhibition is observed in cells that express relatively high amounts of PR (cells poised to decrease expression). We note that relatively greater PR activation in cells with low basal expression is not restricted to agRNAs. 17β-estradiol also activates PR expression much more robustly in low-PR expressing MCF7 cells than in higher-PR expressing T47D cells.
There are many examples of proteins acting as either activators or repressors depending on context [43] [44] [45] , on binding to accessory proteins 46, 47 or on antagonist and agonist binding 48 . Noncoding RNAs can also either activate or repress transcription through interactions with proteins at promoters, possibly through regulating transcriptional coactivator and corepressor complexes 49 .
The transcriptional control machinery can adapt to different stimuli to produce different effects, and this versatility probably underlies the observed mechanism of agRNA action. Conversely, the ability of 3′ agRNAs to modulate gene expression over seemingly large genomic distances emphasizes the remarkable diversity of macromolecules and mechanisms affecting transcription and the power of RNA as a genetic regulator. mETHoDS Cell culture. T47D, MCF7 and MDA-MB-231 cells were cultured at 5% (v/v) CO 2 in RPMI medium (Sigma) supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals), 10 mM HEPES, 0.5% (v/v) non-essential amino acids, 10 μg ml −1 insulin and 1 mM sodium pyruvate (Sigma). For some experiments, T47D or MCF7 cells were cultured in medium containing 5% (v/v) dextran and charcoal-stripped FBS (Atlanta Biologicals) 3 d before treatment with either 17β-estradiol (E2) (Steraloids), epidermal growth factor (EGF) (Sigma) or interleukin-1β (Sigma). addition of the 3′ agRNa recruits ago2 to the 3′ noncoding transcript. the arrival of ago2 may affect other proteins (here shown as unlabeled spheres) at the gene promoter and alter regulation of transcription. the proximity of 3′ and 5′ noncoding transcripts allows them to coimmunoprecipitate during RIP with anti-ago antibodies. CDs, coding sequence.
Cellular delivery of duplex
